跳至: [中文]   [数字0-9]   [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ] 请输入前几个字:

显示项目3651-3675 / 13423. (共537页) << < 142 143 144 145 146 147 148 149 150 151 > >> 每页显示[10|25|50]项目

日期	题名	關聯
2007-01-23	Directional shear flow and Rho activation prevent the endothelial cell apoptosis induced by micropatterned anisotropic geometry	Proceedings of the National Academy of Sciences of the United States of America. 2007 Jan;104(4):1254-1259.
2006-11	Directly measured insulin resistance and the assessment of clustered cardiovascular risks in hypertension	American Journal of Hypertension. 2006 Nov;19(11):1118-1124.
2014-05	Directly thiolated modification onto the surface of detonation nanodiamonds	ACS Applied Materials and Interfaces. 2014 May;6(10):7198-7203.
2005-10	Disabling conditions related to urinary incontinence in older women	Gerontologist. 2005 Oct;45:120-121.
2001-11	Disaster epidemiology and medical response in the Chi-Chi earthquake in Taiwan	Annals of Emergency Medicine. 2001 Nov;38(5):549-555.
2022-08-17	Disclosing an in-frame deletion of the titin gene as the possible predisposing factor of anthracycline-induced cardiomyopathy: A case report	International Journal of Molecular Sciences. 2022 Aug 17;23(16):Article number 9261.
2020-03-31	Discoidin domain receptor-1 (DDR1) is involved in angiolymphatic invasion in oral cancer	Cancers. 2020 Mar 31;12(4):Article number 841.
2002-03-08	Discontinuation of secondary prophylaxis for penicilliosis marneffei in AIDS patients responding to highly active antiretroviral therapy	AIDS. 2002 Mar;16(4):672-673.
2024-07-25	Discordant phenotypes of nephritis in patients with X-linked agammaglobulinemia	Journal of Clinical Immunology. 2024 Jul 25;44(7):Article number 164.
2022-11-02	Discovering a trans-omics biomarker signature that predisposes high risk diabetic patients to diabetic kidney disease	Npj Digital Medicine. 2022 Nov 02;5:Article number 166.
2022-02-05	Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug design	European Journal of Medicinal Chemistry. 2022 Feb 5;229:Article number 114043.
2018-01	Discovery and development of DBPR112 as a clinical candidate: A novel EGFR inhibitor for non-small cell lung cancer	Cancer Science. 2018 Jan;109(Suppl. 1):739.
2009-03	Discovery and development of novel furano-pyrimidine analogs as Aurora kinase inhibitors	Abstracts of Papers - American Chemical Society. 2009 Mar;237:MEDI 221.
2016-04	Discovery and development of tylophorine derived dibenzoquinolines-33b compounds into therapeutic agents	The FASEB Journal. 2016 Apr;30(1, Suppl.):Meeting Abstract lb56.
2011-07	Discovery and evaluation of 3-phenyl-1H-5-pyrazolylamine-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)	Bioorganic and Medicinal Chemistry. 2011 Jul;19(14):4173-4182 .
2013-11	Discovery and refinement of loci associated with lipid levels	Nature Genetics. 2013 Nov;45(11):1274-1283.
2014-08	Discovery and structure-activity relationships of phenyl benzenesulfonylhydrazides as novel indoleamine 2,3-dioxygenase inhibitors	Bioorganic and Medicinal Chemistry Letters. 2014 Aug;24(15):3403-3406.
2021-05-19	Discovery and synthesis of a pyrimidine-based aurora kinase inhibitor to reduce levels of MYC oncoproteins	Journal of Medicinal Chemistry. 2021 May 19;64(11):7312-7330.
2010-09	Discovery of 1-(2,4-Dichlorophenyl)-4-ethyl-5-(5-(2-(4-(trifluoromethyl)phenyl)ethynyl)thiophe n-2-yl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide as a potential peripheral cannabinoid-1 receptor inverse agonist	ChemMedChem. 2010 Sep;5(9):1439-1443.
2013-11-13	Discovery of 1-(2,4-Dichlorophenyl)-N-(piperidin-1-yl)-4-((pyrrolidine-1-sulfonamido)methyl)-5 -(5-((4-(trifluoromethyl)phenyl)ethynyl)thiophene-2-yl)-1H-pyrazole-3-carboxamide as a novel peripherally restricted cannabinoid-1 receptor antagonist with significant weight-loss efficacy in diet-induced obese mice	Journal of Medicinal Chemistry. 2013 Nov 13;56(24):9920-9933.
2015-08	Discovery of 2,4-diaminopyrimidines bearing a unique pharmacophore as anaplastic lymphoma kinase inhibitors	Abstracts of Papers of the American Chemical Society. 2015 Aug;250:Meeting Abstract 182.
2009-07-23	Discovery of 2-[5-(4-chloro-phenyl)-1-(2,4-dichloro-phenyl)-4-ethyl-1H-pyrazol-3-yl]-1,5,5-trimethyl-1,5-dihydro-imidazol-4-thione (BPR-890) via an active metabolite. A novel, potent and selective cannabinoid-1 receptor inverse agonist with high antiobesity efficacy in DIO mice	Journal of Medicinal Chemistry. 2009 Jul 23;52(14):4496-4510.
2013-06	Discovery of 3-phenyl-1H-5-pyrazolylamine derivatives containing a urea pharmacophore as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)	Bioorganic and Medicinal Chemistry. 2013 Jun;21(11):2856-2867.
2008-07-24	Discovery of 4-amino and 4-hydroxy-1-aroylindoles as potent tubulin polymerization inhibitors	Journal of Medicinal Chemistry. 2008 Jul;51(14):4351-4355.
2022-06-02	Discovery of a biomarker signature that reveals a molecular mechanism underlying diabetic kidney disease via organ cross talk	Diabetes Care. 2022 Jun 2;45(6):e102-e104.

显示项目3651-3675 / 13423. (共537页) << < 142 143 144 145 146 147 148 149 150 151 > >> 每页显示[10|25|50]项目